Cboe Global Markets vs Marex
CBOE and MRX side by side, both in security & commodity brokers, dealers, exchanges & services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBOE and MRX compare
Marex grew revenue faster over the last twelve months (26.9% versus 14.3% for Cboe Global Markets).
Cboe Global Markets keeps more of each dollar of sales as profit, with a net margin of 28.0% compared with 14.5% at Marex.
Cboe Global Markets pays a dividend yielding 0.61%; Marex does not pay one.
Cboe Global Markets scores higher on the StockData Score (20 against 9 for Marex), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBOE | MRX |
|---|---|---|
| Size and price | ||
| Market cap | $39.2B | – |
| Share price | $375.42 | $70.72 |
| Change, 1 year | 43.9% | 103% |
| Change, 5 years | 190% | – |
| Beta (5Y) | 0.24 | 0.46 |
| Employees | 1,661 | 3,109 |
| StockData Score | ||
| Total score | 20 (better) | 9 |
| Valuation score | 1 (better) | 0 |
| Growth score | 3 | 3 |
| Performance score | 6 (better) | 3 |
| Health score | 6 (better) | 3 |
| Dividend score | 4 (better) | 0 |
| Valuation | ||
| P/E | 26.7× | – |
| P/S | 7.4× | – |
| P/B | 6.6× | – |
| EV/EBITDA | 18.6× | – |
| P/FCF | 15.5× | – |
| PEG | 0.39 | – |
| FCF yield | 6.5% | – |
| Fair value | $328.57 | – |
| Margin of safety | −14.3% | – |
| Growth | ||
| Revenue growth (TTM) | 14.3% | 26.9% (better) |
| Revenue growth, 5Y average | 6.6% | – |
| Net income growth (TTM) | 50.6% (better) | 43.6% |
| EPS growth (TTM) | 51.0% (better) | 41.9% |
| EPS growth, 5Y average | 19.5% | – |
| Profitability | ||
| Gross margin | 53.9% | – |
| Operating margin | 36.4% | – |
| Net margin | 28.0% (better) | 14.5% |
| FCF margin | 47.9% (better) | 32.3% |
| Return on equity | 27.4% | 28.7% (better) |
| Return on invested capital | 36.2% | – |
| Financial health | ||
| Debt / equity | 0.24 | 0.17 (better) |
| Net debt / EBITDA | −0.62 | −2.22 |
| Interest coverage | 36.3× | – |
| Current ratio | 1.61 (better) | 1.09 |
| Altman Z-score | 6.29 | – |
| Piotroski F-score | 9 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 0.61% | – |
| Payout ratio | 21.4% | 18.9% |
| Years of dividend growth | 11 | – |
| Dividend growth, 5Y average | 11.6% | – |
| Buyback yield | 0.34% | – |
| Shareholder yield | 0.95% | – |
| Ownership | ||
| Held by institutions | 89.2% | 77.6% |
| Held by insiders | 0.25% | 8.4% |
| Insider net buying, 12 months | −$2.3M (better) | −$19.8M |
| Superinvestors holding | 1 | – |
| Short interest, % of float | 2.0% | 3.3% |
Go deeper
- CBOE stock overview
- CBOE income statement
- CBOE valuation and score
- MRX stock overview
- MRX income statement
- MRX valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.